Doxorubicin Pharmintraco 10 mg, lyophilisat Швајцарска - Немачки - Swissmedic (Swiss Agency for Therapeutic Products)

doxorubicin pharmintraco 10 mg, lyophilisat

ingenus pharmaceuticals gmbh - doxorubicini hydrochloridum - 10 mg, lyophilisat - vorbereitung cryodesiccata: doxorubicini hydrochloridum 10 mg, lactosum monohydricum, für glas. - zytostatika - synthetika

Doxorubicin Pharmintraco 20 mg, lyophilisat Швајцарска - Немачки - Swissmedic (Swiss Agency for Therapeutic Products)

doxorubicin pharmintraco 20 mg, lyophilisat

ingenus pharmaceuticals gmbh - doxorubicini hydrochloridum - 20 mg, lyophilisat - vorbereitung cryodesiccata: doxorubicini hydrochloridum 20 mg, lactosum monohydricum, für glas. - zytostatika - synthetika

Doxorubicin Pharmintraco 50 mg, lyophilisat Швајцарска - Немачки - Swissmedic (Swiss Agency for Therapeutic Products)

doxorubicin pharmintraco 50 mg, lyophilisat

ingenus pharmaceuticals gmbh - doxorubicini hydrochloridum - 50 mg, lyophilisat - vorbereitung cryodesiccata: doxorubicini hydrochloridum 50 mg, lactosum monohydricum, für glas. - zytostatika - synthetika

Doxorubicinhydrochlorid Teva 2 mg/ml Konzentrat zur Herstellung einer Infusionslösung Немачка - Немачки - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

doxorubicinhydrochlorid teva 2 mg/ml konzentrat zur herstellung einer infusionslösung

bb farma s.r.l. (8126628) - doxorubicinhydrochlorid - konzentrat zur herstellung einer infusionslösung - teil 1 - konzentrat zur herstellung einer infusionslösung; doxorubicinhydrochlorid (06460) 2 milligramm

Zolsketil pegylated liposomal Европска Унија - Немачки - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Adrimedac 10mg Немачка - Немачки - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

adrimedac 10mg

pharmachemie b.v. (3189127) - doxorubicinhydrochlorid - injektionslösung - teil 1 - injektionslösung; doxorubicinhydrochlorid (06460) 10 milligramm

axidoxo 2 mg/ml Infusionslösung Немачка - Немачки - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

axidoxo 2 mg/ml infusionslösung

axionovo gmbh - geschäftsanschrift - (8185708) - doxorubicinhydrochlorid - infusionslösung - teil 1 - infusionslösung; doxorubicinhydrochlorid (06460) 2 milligramm

Adriblastina 10 Ready To Use 10 mg Injektionslösung Белгија - Немачки - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

adriblastina 10 ready to use 10 mg injektionslösung

pfizer - doxorubicin-hydrochlorid - injektionslösung - 10 mg - doxorubicin-hydrochlorid 10 mg - doxorubicin